Gritstone bio Inc. (NASDAQ:GRTS) went up by 2.20% from its latest closing price compared to the recent 1-year high of $14.42. The company’s stock price has collected -0.31% of loss in the last five trading sessions. The Wall Street Journal reported on 01/19/21 that Tesla, GameStop, Coherent: What to Watch When the Stock Market Opens Today
Is It Worth Investing in Gritstone bio Inc. (NASDAQ :GRTS) Right Now?
Plus, the 36-month beta value for GRTS is at 0.64. Opinions of the stock are interesting as 4 analysts out of 5 who provided ratings for Gritstone bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $8.75, which is $5.5 above the current price. GRTS currently public float of 81.20M and currently shorts hold a 7.14% ratio of that float. Today, the average trading volume of GRTS was 762.49K shares.
GRTS’s Market Performance
GRTS stocks went down by -0.31% for the week, with a monthly jump of 32.65% and a quarterly performance of -7.67%, while its annual performance rate touched -68.07%. The volatility ratio for the week stands at 9.37% while the volatility levels for the past 30 days are set at 11.37% for Gritstone bio Inc. The simple moving average for the period of the last 20 days is 11.36% for GRTS stocks with a simple moving average of 0.98% for the last 200 days.
Analysts’ Opinion of GRTS
Many brokerage firms have already submitted their reports for GRTS stocks, with Piper Sandler repeating the rating for GRTS by listing it as a “Overweight.” The predicted price for GRTS in the upcoming period, according to Piper Sandler is $6 based on the research report published on October 31st of the current year 2022.
Goldman, on the other hand, stated in their research note that they expect to see GRTS reach a price target of $2. The rating they have provided for GRTS stocks is “Sell” according to the report published on August 22nd, 2022.
Goldman gave a rating of “Neutral” to GRTS, setting the target price at $15 in the report published on December 15th of the previous year.
GRTS Trading at 17.69% from the 50-Day Moving Average
After a stumble in the market that brought GRTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.46% of loss for the given period.
Volatility was left at 11.37%, however, over the last 30 days, the volatility rate increased by 9.37%, as shares surge +35.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.67% lower at present.
During the last 5 trading sessions, GRTS fell by -0.31%, which changed the moving average for the period of 200-days by -41.12% in comparison to the 20-day moving average, which settled at $2.96. In addition, Gritstone bio Inc. saw -74.73% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at GRTS starting from Jones Erin, who sale 1,000 shares at the price of $13.01 back on Dec 01. After this action, Jones Erin now owns 45,900 shares of Gritstone bio Inc., valued at $13,010 using the latest closing price.
Stock Fundamentals for GRTS
Current profitability levels for the company are sitting at:
- -164.19 for the present operating margin
- +69.18 for the gross margin
The net margin for Gritstone bio Inc. stands at -160.72. Equity return is now at value -67.00, with -50.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 5.52.